Börse von finanzen.net | Aktien-Nachrichten | Marktberichte

DAX	6.050	-3,4%	Dow	12.119	-2,2%	Euro	1,2432	0,6%
ESt50	2.069	-2,4%	Nas	2.748	-2,8%	Öl	98,82	-2,8%
TDax	730,9	-2,7%	Nikkei	8.440	-1,2%	Gold	1.626	4,2%

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (groß)	News + Adhoc	Bilanz/GuV	Termine	Zertifikate	Depot
Times + Sales	Chart-Analyse	Analysen	Dividende/HV	Profil	Optionsscheine	Watchlist
Börsenplätze	Chartvergleich	Kursziele		Insidertrades	Knock-outs	myHome
Orderbuch	Realtime Stuttgart	RSS Feed	Analyse	im Forum	Fonds	Senden
Historisch	Realtime Push	myNews neu		IR-Daten	Anleihen	handeln

24.04.12	bioMérieux - First-Quarter 2012 Business Review
13.03.12	bioMérieux - 2011 Financial Results
14.02.12	bioMérieux: Press Release
24.01.12	bioMérieux - 2011 Business Review
14.12.11	bioMérieux: Additional Information Following the December 7th Press Release
07.12.11	bioMérieux - Information on 2011 Sales Objective
18.11.11	bioMérieux Initiative to Support European Antibiotic Awareness Day
20.10.11	bioMérieux: Business Review for the Nine Months Ended September 30, 2011
06.09.11	bioMérieux - First-Half Results at June 30, 2011
19.07.11	bioMérieux Expands Its Infectious Disease Offering with Acquisition of ARGENE, Specialized in Molecular Diagnostics for Immunocompromised Patients

19.07.11	bioMérieux - First-Half 2011 Business Review
30.06.11	bioMérieux: World HAI Forum: Global Call to Action to Fight Antibiotic Resistance
22.06.11	bioMérieux Launches Groundbreaking Salmonella Detection Technology to Improve Food Safety
22.06.11	GE Capital, Franchise Finance Provides $18.5 Million to Hampton Inn & Suites’ and Homewood Suites’ Hotel Company, K Partners Hospitality Group, L.P.
24.05.11	bioMérieux Receives FDA Clearance for NucliSENS EasyQ® MRSA, Automated, Rapid Molecular Screening Test
24.05.11	bioMérieux Receives FDA Clearance for NucliSENS EasyQ® MRSA, Automated, Rapid Molecular Screening Test
19.05.11	Opnext Reports Fourth Quarter and Full Year Unaudited Operating Results
19.05.11	bioMérieux Becomes the World Leader in Food Testing with AES Laboratoire Acquisition
21.04.11	FreightCar America, Inc. Announces First Quarter 2011 Earnings Conference Call
21.04.11	OriginOil Receives "50 Hottest Companies in Bioenergy" Award
21.04.11	Philips Lumileds Introduces LUXEON A, Its Latest Illumination Grade LED
21.04.11	bioMérieux - First-Quarter 2011 Business Review
08.03.11	bioMérieux - 2010 Financial Results
08.03.11	Aberdeen Emerging Markets Telecommunications and Infrastructure Fund, Inc. Announces Performance Data and Portfolio Composition
25.02.11	Ipsen and bioMérieux Enter into a Broad Partnership in Personalized Medicine
19.01.11	Kaydon Corporation Announces Fourth Quarter and Full Year 2010 Earnings Conference Call
19.01.11	bioMérieux – 2010 Business Review
19.01.11	bioMérieux – 2010 Business Review
04.01.11	bioMérieux Expands Customer Services Offer, Appointing James P. Whelan as Executive Vice President, Commercial Services
04.01.11	Porsche Reports Significant Sales Increase for 2010
01.12.10	bioMérieux Restructures Its Clinical Culture Media Business in North America and Announces the Closing of Its Portland, OR Plant
01.12.10	Certain Invesco Van Kampen Closed-End Funds Declare Dividends
01.12.10	BreitBurn Energy Partners to Present at the 9th Annual Wells Fargo Securities Pipeline and MLP Symposium on December 7
04.11.10	bioMérieux and Biocartis Sign Strategic Partnership in Molecular Diagnostics
26.10.10	Alain Mérieux Organizes his Succession at the Head of bioMérieux, Entrusting Jean-Luc Bélingard with the Role of Président Directeur Général
26.10.10	Tenneco to Webcast Presentation at the 34th Annual Gabelli & Company Automotive Aftermarket Symposium Conference
22.10.10	bioMérieux Business Review for the nine months ended September 30, 2010
06.09.10	bioMérieux - First-Half 2010 Results
22.07.10	bioMérieux - First-Half 2010 Business Review
25.05.10	bioMérieux Showcases Myla™ at ASM 2010: New Informatics Solution to Transform the Microbiology Laboratory

Finanzen.net

BioMerieuxAct Aktie [WKN: A0B577 / ISIN: FR0010096479]

Hinweis

Newssuche

ALLE Nachrichten zur BioMerieuxAct.

Anzeige

ANZEIGE